147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
More posts

Mouse anti mouse ccl5 monoclonal antibody (clone 2e9)

Mouse monoclonal antibody directed against mouse CCL5. Antibody was produced by immunising CCL5 KO mice with recombinant CCL5. […]

Establishment of redifferentiated cells after treatment of neoplastic

When undifferentiated, invasive neoplastic cell lines are treated with an optimal time / concentration combination of curcumin (under conditions […]

Ht29-mtx cells : intestinal model of goblet cells

HT29MTX10-6 and HT29MTX10-5 cell populations were isolated from the colon cancer cell line by stepwise adaptation to 10-6 M and 10-5 M Methotrexate […]

New production system for human recombinant leptin

Leptin is an adipocyte-derived pleiotropic hormone that modulates a large number of physiological functions, including control of body weight and […]

A breast-cancer cell line expressing a bret biosensor to monitor pi-3

We have developed a MCF7-derived cell line stably co-expressing the pleckstrin homology (PH) domain of Akt fused to Renilla luciferase (Luc-Akt-PH) […]

Lgi1-null mouse: a model for epilepsy

LGI1 (leucine-rich, glioma-inactivated 1) mutations are responsible for an inherited focal epileptic syndrome with onset in adolescence. LGI1-related […]

More posts

You might also be interested in